| Study Group (Bemiparin +) | Control Group (Bemiparin −) | p |
Live Birth | 60 (93.75%) | 32 (57.14%) | 0.001** |
Still Birth | 0 | 0 |
|
Abortion | 4 (6.25%) | 24 (42.85%) | 0.001** |
Total | 64 | 56 |
|